Neil Dhawan

Neil Dhawan

Company: Totus Medicines

Job title: Chief Executive, Scientific Officer & Co-founder


Developing Ultra-High Throughput Cellular Screening of Covalent Libraries & the Advancement of a PI3K-alpha Covalent Inhibitor 12:30 pm

Elucidating the development of the first ever platform to screen billions of covalent compounds in cells in days Discussing the discovery of TOS-358, the first highly specific covalent inhibitor of PI3K-alpha Case Study: The unique properties and advantages of covalent targeting of PI3K-alphaRead more

day: Conference Day One

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.